These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9615841)

  • 1. The pharmacologic and clinical properties of Oxis (formoterol) Turbuhaler.
    Selroos O
    Allergy; 1998; 53(42 Suppl):14-9. PubMed ID: 9615841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose comparison of formoterol (Oxis) Turbuhaler 6 microg and formoterol Aerolizer 12 microg in moderate to severe asthma: a randomised, crossover study.
    Schlimmer P
    Pulm Pharmacol Ther; 2002; 15(4):369-74. PubMed ID: 12220942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined budesonide/formoterol turbuhaler treatment of asthma.
    Remington TL; Heaberlin AM; DiGiovine B
    Ann Pharmacother; 2002 Dec; 36(12):1918-28. PubMed ID: 12452756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formoterol delivered by Turbuhaler: in pediatric asthma.
    Cheer SM; Warner GT; Easthope SE
    Paediatr Drugs; 2003; 5(1):63-8; discussion 69. PubMed ID: 12513109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and efficacy of formoterol (Oxis) turbuhaler plus budesonide (Pulmicort) turbuhaler in mild to moderate asthma: a comparison with budesonide Turbuhaler alone and current non-corticosteroid therapy in Russia.
    Chuchalin AG; Ovcharenko SI; Goriachkina LA; Sidorenko IV; Tsoi AN;
    Int J Clin Pract; 2002; 56(1):15-20. PubMed ID: 11833550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formoterol Turbuhaler 4.5 microg (delivered dose) has a rapid onset and 12-h duration of bronchodilation.
    Selroos O; Ekström T
    Pulm Pharmacol Ther; 2002; 15(2):175-83. PubMed ID: 12090792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics.
    Rosenborg J; Bengtsson T; Larsson P; Blomgren A; Persson G; Lötvall J
    Eur J Clin Pharmacol; 2000 Aug; 56(5):363-70. PubMed ID: 11009043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose formoterol Turbuhaler (Oxis) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.).
    Ekström T; Ringdal N; Sobradillo V; Runnerström E; Soliman S
    Respir Med; 1998 Aug; 92(8):1040-5. PubMed ID: 9893773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar bronchodilation with formoterol delivered by aerolizer or turbuhaler.
    Lötvall J; Mellén A; Arvidsson P; Palmqvist M; Radielovic P; Kottakis J; Pfister P
    Can Respir J; 1999; 6(5):412-6. PubMed ID: 10572207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of formoterol Turbuhaler at cumulative dose of 90 microg in patients with acute bronchial obstruction.
    Malolepszy J; Böszörményi Nagy G; Selroos O; Larsso P; Brander R
    Eur Respir J; 2001 Dec; 18(6):928-34. PubMed ID: 11829098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma.
    Berger WE; Bleecker ER; O'Dowd L; Miller CJ; Mezzanotte W
    Allergy Asthma Proc; 2010; 31(1):49-59. PubMed ID: 20167145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma.
    Lalloo UG; Malolepszy J; Kozma D; Krofta K; Ankerst J; Johansen B; Thomson NC
    Chest; 2003 May; 123(5):1480-7. PubMed ID: 12740264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effects of inhaled formoterol and budesonide in reducing asthma exacerbations.
    Pauwels R
    Allergy; 1998; 53(42 Suppl):20-3. PubMed ID: 9615842
    [No Abstract]   [Full Text] [Related]  

  • 17. Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.
    Berger WE; Gillen M; Eckerwall G; Uryniak T; Trudo FJ; Lampl KL
    Allergy Asthma Proc; 2014; 35(2):134-40. PubMed ID: 24717790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
    Kerwin EM; Oppenheimer JJ; LaForce C; Parasuraman B; Miller CJ; O'Dowd L; Goldman M
    Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formoterol used as needed in patients with intermittent or mild persistent asthma.
    Chuchalin A; Kasl M; Bengtsson T; Nihlen U; Rosenborg J
    Respir Med; 2005 Apr; 99(4):461-70. PubMed ID: 15763453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study.
    FitzGerald JM; Sears MR; Boulet LP; Becker AB; McIvor AR; Ernst P; Smiljanic-Georgijev NM; Lee JS;
    Can Respir J; 2003; 10(8):427-34. PubMed ID: 14679407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.